SCHEMBL9187068

SCHEMBL9187068

OC(CNc1cccc2ncccc12)CN1CCN(C2c3ccccc3CCc3ccccc32)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 4/20 0.53
▸ RRM1 P23921 1/20 0.43
▸ NR3C1 P04150 2/20 0.41
▸ FNTA P49354 2/20 0.40
▸ FNTB P49356 2/20 0.40
▸ HDAC3 O15379 1/20 0.38
▸ HDAC4 P56524 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC7 Q8WUI4 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC10 Q969S8 1/20 0.38
▸ HDAC11 Q96DB2 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ HDAC9 Q9UKV0 1/20 0.38
▸ HDAC5 Q9UQL6 1/20 0.38
▸ NCOR2 Q9Y618 1/20 0.38
▸ CARM1 Q86X55 1/20 0.37
▸ GPBAR1 Q8TDU6 1/20 0.37
▸ BACE1 P56817 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8299655 0.82 ABCB1 (0.76) ABCB1RRM1NR3C1
SCHEMBL8435621 0.82 ABCB1 (0.76) ABCB1RRM1NR3C1
SCHEMBL29640402 0.82 ABCB1 (0.76) ABCB1RRM1NR3C1
SCHEMBL8644069 0.82 ABCB1 (0.76) ABCB1RRM1NR3C1
SCHEMBL9181583 0.81 ABCB1 (0.55) ABCB1RRM1FNTAFNTB
SCHEMBL9187135 0.80 ABCB1 (0.51) ABCB1RRM1FNTAFNTBHRH3
SCHEMBL9186633 0.79 ABCB1 (0.71) ABCB1RRM1NR3C1PRMT5WDR77
SCHEMBL9181681 0.79 ABCB1 (0.49) ABCB1BACE1
SCHEMBL9181903 0.78 HDAC8 (0.52) FNTAFNTBHDAC3HDAC1HDAC2
SCHEMBL9181999 0.77 ABCB1 (0.49) ABCB1RRM1FNTAFNTBPRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 — — US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 — — EP disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 — — US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 — — US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 — — EP disclosed
Send feedback